12Jul/13

BOLERO 3: Everolimus may overcome trastuzumab resistance in HER2-positive … – The Oncology Report

BOLERO 3: Everolimus may overcome trastuzumab resistance in HER2-positive
The Oncology Report
CHICAGO – The mTOR inhibitor everolimus appears to be effective at overcoming trastuzumab resistance in patients with advanced HER2-positive breast cancer, based on findings from the BOLERO-3 trial. The 572 patients studied all had locally advanced 

and more »

12Jul/13

Nelson Mandela continues to respond to treatment: Presidency – Daily News & Analysis


Daily News & Analysis

Nelson Mandela continues to respond to treatment: Presidency
Daily News & Analysis
The statement came as Mandela spent his 34th day at the Mediclinic Heart Hospital in Pretoria after being rushed there with a serious recurring lung infection June 8, Xinhua reported. President Jacob Zuma visited Mandela in hospital Thursday, wishing
South Africa’s Mandela remains critical, responds to treatmentReuters India
Mandela responding to treatment: Presidencyindiablooms
Nelson Mandela ‘continues to respond to treatment’Zee News
Newstrack India
all 120 news articles »